Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The Genetic Epidemiology and Risk Assessment Program studies patterns, risk factors and genes linked to cancer. By leveraging large observational studies and cutting-edge molecular technologies and statistical analyses, researchers investigate important questions about cancer and its development.
The Genetic Epidemiology and Risk Assessment Program digs deep into the causes behind cancer, working toward a goal of improving diagnosis, treatment and outcomes for patients.
Driven by the need to better understand the origins of cancer, numerous researchers collaborate to explore genetic influences, develop statistical methods and leverage large patient cohorts.
Contact the program about its research on the causes and risk factors behind cancer development or about collaborative cancer research opportunities.
The Genetic Epidemiology and Risk Assessment Program is part of the Mayo Clinic Cancer Center, an NCI-designated comprehensive cancer center with locations in Arizona, Florida and Minnesota.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.